Table 2 Clinical and laboratory data of the patients included in each study
First Author | Number of wrists | Gender (M/F) | Mean age (years) | Severity | Serum Vitamin D (ng/ml) | Form and Dose | Duration (weeks) | Other Treatments | |
|---|---|---|---|---|---|---|---|---|---|
Before | After | ||||||||
Samant et al. [36] | 42 | 9/33 | 40.88 ± 7.6 | Mild and Moderate CTS | 13.73 ± 3.9 | 46.61 ± 5.8 | Oral Vitamin D3; dose 60,000 IU/week | 12 | Analgesics, Anti-inflammatory drugs, Splint, Physiotherapy |
Saçmaci et al. [35] | 82 | 0/55 | 48.04 ± 6.03 in Mild CTS, 45.97 ± 7.97 in Moderate CTS | 45 Mild CTS and 37 Moderate CTS | 11.75 ± 4.53 in Mild CTS, 11.64 ± 3.55 in Moderate CTS | 39.97 ± 16.02 in Mild CTS, 32.45 ± 13.99 in Moderate CTS | Oral Vitamin D2 or D3; dose 6000 IU/day or 50,000 IU/week | 12 | Splint |
Lee et al. [21] | 84 | 0/84 | 56 ± 9 | Not reported | 12 ± 3.6 | 24.5 ± 8.5 | Oral Vitamin D; dose 1000 IU/day | 24 | Carpal tunnel release |
Mohtashamkia et al. [26] | 50 | Not reported | 44 ± 8.5 | Mild and Moderate CTS | 19.1 ± 6.3 | Not reported | Oral Vitamin D3; dose 50,000 IU/week | 12 | Anti-inflammatory drugs, Splint, Physiotherapy |